Patent Assignment
Reel/Frame 059185/0461
Assignment of Assignor's Interest
Recorded: 2022-03-07
Pages: 5
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Plasma Kallikrein Inhibitors and Uses Thereof
PCT:
PCT/US2020/051293 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 21, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 058726/0395 →
Assignment of Assignor's Interest
Jan 21, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 058726/0408 →
Assignment of Assignor's Interest
Jan 21, 2022
From: PAPAIOANNOU, NIKOLAOS; TRAVINS, JEREMY MARK; FINK, SARAH JOCELYN
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058726/0446 →
Assignment of Assignor's Interest
Jan 21, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058726/0476 →
Assignment of Assignor's Interest
Jan 21, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058726/0493 →
Assignment of Assignor's Interest
Jan 21, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 058726/0499 →